Vergleich

MAPK9 Antibody, KO Validated

ArtNr PRS-14-471-50uL
Hersteller ProSci
Menge 50 uL
Quantity options 100 uL
Kategorie
Typ Antibody Primary
Format Liquid
Applikationen WB, IF, IHC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host Rabbit
Isotype IgG
Konjugat/Tag Unconjugated
NCBI MAPK9
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias MAPK9, stress-activated protein kinase JNK2, SAPK, PRKM9, p54aSAPK, p54a, OTTHUMP00000161543, OTTHUMP00000161542, mitogen-activated protein kinase 9, MAPK 9, MAP kinase 9, Jun kinase, JNK-55, JNK2BETA, JNK2B, JNK2ALPHA, JNK2A, JNK2, c-Jun N-terminal kinas
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Type
Primary Antibodies
Shipping Temperature
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Molecular Weight
Observed: 54kDa
Manufacturer - Research Area
Apoptosis, Cancer, Cell Cycle, Immunology, Innate Immunity, Neuroscience, Signal Transduction
Background
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene's mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported.
By Type
Apoptosis, Cancer, Cell Cycle, Immunology, Innate Immunity, Neuroscience, Signal Transduction
Modifications
None
Purification
Affinity purification
Validation
Antibody is Knockout validated.
Positive Control 1
MCF-7
Positive Control 2
DU145
Positive Control 3
THP-1
Concentration
batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Application Note
WB: 1:500 - 1:2000
IHC: 1:50 - 1:200
IF: 1:50 - 1:200
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1-424 of human MAPK9 (NP_002743.3).
Clonality
Polyclonal
NCBI Official Name
mitogen-activated protein kinase 9
NCBI Organism
Homo sapiens
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
User Note
Optimal dilutions for each application to be determined by the researcher.
Validation
Antibody is Knockout validated.
Manufacturer - Additional Names
MAPK9, stress-activated protein kinase JNK2, SAPK, PRKM9, p54aSAPK, p54a, OTTHUMP00000161543, OTTHUMP00000161542, mitogen-activated protein kinase 9, MAPK 9, MAP kinase 9, Jun kinase, JNK-55, JNK2BETA, JNK2B, JNK2ALPHA, JNK2A, JNK2, c-Jun N-terminal kinase 2, c-Jun kinase 2, SAPK1A

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

 
Schließen